1. Home
  2. CMPX vs DSP Comparison

CMPX vs DSP Comparison

Compare CMPX & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$2.22

Market Cap

408.8M

Sector

Health Care

ML Signal

HOLD

Logo Viant Technology Inc.

DSP

Viant Technology Inc.

HOLD

Current Price

$13.57

Market Cap

279.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMPX
DSP
Founded
2014
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
408.8M
279.6M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
CMPX
DSP
Price
$2.22
$13.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
8
Target Price
$14.57
$17.81
AVG Volume (30 Days)
2.6M
263.5K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.14
EPS
N/A
N/A
Revenue
N/A
$344,201,000.00
Revenue This Year
N/A
$20.27
Revenue Next Year
$934.41
$16.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.00
52 Week Low
$1.61
$8.11
52 Week High
$6.88
$14.80

Technical Indicators

Market Signals
Indicator
CMPX
DSP
Relative Strength Index (RSI) 45.53 59.55
Support Level $1.88 $10.36
Resistance Level $2.23 $14.16
Average True Range (ATR) 0.12 0.57
MACD -0.02 0.08
Stochastic Oscillator 2.90 90.69

Price Performance

Historical Comparison
CMPX
DSP

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising technology company engaged in providing a cloud-based demand-side platform (DSP) for programmatic advertising. The company enables marketers and advertising agencies to plan, buy, and measure digital advertising campaigns across multiple channels, including connected TV, streaming audio, mobile, desktop, and digital out-of-home. Its platform leverages data integrations and proprietary identity solutions to deliver targeted advertising, audience insights, and performance measurement.

Share on Social Networks: